Dept of Internal Medicine V, Comprehensive Pneumology Center (CPC-M), Member of the German Center for Lung Research (DZL), University of Munich, Munich, Germany
Both authors contributed equally.
Eur Respir J. 2017 Apr 12;49(4). doi: 10.1183/13993003.01315-2016. Print 2017 Apr.
Identification of disease phenotypes might improve the understanding of patients with chronic lung allograft dysfunction (CLAD). The aim of the study was to assess the impact of pulmonary restriction and air trapping by lung volume measurements at the onset of CLAD.A total of 396 bilateral lung transplant recipients were analysed. At onset, CLAD was further categorised based on plethysmography. A restrictive CLAD (R-CLAD) was defined as a loss of total lung capacity from baseline. CLAD with air trapping (AT-CLAD) was defined as an increased ratio of residual volume to total lung capacity. Outcome was survival after CLAD onset. Patients with insufficient clinical information were excluded (n=95).Of 301 lung transplant recipients, 94 (31.2%) developed CLAD. Patients with R-CLAD (n=20) and AT-CLAD (n=21), respectively, had a significantly worse survival (p<0.001) than patients with non-R/AT-CLAD. Both R-CLAD and AT-CLAD were associated with increased mortality when controlling for multiple confounding variables (hazard ratio (HR) 3.57, 95% CI 1.39-9.18; p=0.008; and HR 2.65, 95% CI 1.05-6.68; p=0.039). Furthermore, measurement of lung volumes was useful to identify patients with combined phenotypes.Measurement of lung volumes in the long-term follow-up of lung transplant recipients allows the identification of patients who are at risk for worse outcome and warrant special consideration.
识别疾病表型可能有助于加深对慢性肺移植物功能障碍(CLAD)患者的认识。本研究旨在通过肺量测定评估 CLAD 发病时肺限制和空气潴留的影响。
共分析了 396 例双侧肺移植受者。CLAD 发病时,根据体描仪进一步分类。限制性 CLAD(R-CLAD)定义为总肺容量从基线丢失。伴有空气潴留的 CLAD(AT-CLAD)定义为残气量与总肺容量比增加。结局为 CLAD 发病后的生存情况。排除临床资料不足的患者(n=95)。
301 例肺移植受者中,94 例(31.2%)发生 CLAD。R-CLAD(n=20)和 AT-CLAD(n=21)患者的生存率明显较差(p<0.001),而非 R/AT-CLAD 患者的生存率较差。控制多种混杂变量后,R-CLAD 和 AT-CLAD 均与死亡率增加相关(危险比(HR)3.57,95%CI 1.39-9.18;p=0.008;HR 2.65,95%CI 1.05-6.68;p=0.039)。此外,肺容积测量有助于识别具有联合表型的患者。
在肺移植受者的长期随访中测量肺容积,可以识别出预后较差的患者,并需要特别考虑。